Abstract:Objective To investigate the clinical outcome and effect of interferon treatment on patients with chronic hepatitis C.Methods 136 cases of patients with chronic hepatitis C were followed up by methods of retrospective survey combined with prospective study.SPSS16.0 was used to perform chisquare test and multiple logistic regression.Results 136 cases of patients were infected with HCV virus mainly through blood and blood products transfusion.They were diagnosed mainly between 2000 and 2005.98 cases of them had anti-viral treatment with interferon and ribavirin,while the rest did not; 12 new cases developed HCV-related cirrhosis or liver carcinoma in five years,which accounted for 8.8％ of the total.Among 76 cases once treated with interferon,46 cases (60.5％) relapsed in five years.For patients with age ＜ 40,the rates of cirrhosis and liver cancer were o,and patients with age ≥ 40 but ＜ 60 years,the rates of cirrhosis and liver cancer were 12.5％ (7/56 cases),while for those ≥ 60 years old the rates were 35.7％ (10/28cases).The difference was significant (B =0.111,Wald =4.324,P =0.038) as analysed by logistic regression.The rates of cirrhosis and liver cancer were zero for those with normal or within twice the upper normal AST limit in five years,43.5％ (10/23 cases) for those with AST ranging from 2 to 4 fold the upper normal limit,and 58.3％ (7/12 cases) for those with AST higher than four times the upper normal limit.The difference was also significant (B =2.184,Wald =5.443,P =0.02) by logistic regression analysis.The rate of relapse was 29.7％ (11/37 cases) for those using pegylated interferon and 89.7％ (35/39 cases) for those using interferon.The difference was significant ( Result of logistic regression showed-B =-2.077,Wald =4.352,P =0.037).The rate of relapse was 100％ (15/15 cases) for those with treatment less than 24 weeks,76.2％ (16/21 cases)for those with treatment more than 24 weeks but less than 48 weeks,and 37.5％ (14/40 cases) for those with treatment more than 48 weeks.The difference was significant ( Result of logistic regression showed-B =-1.632,Wald =6.651,P =0.01).42 cases of the relapsed (91.3％) were administrated with interferon once again with ideal effect.Conclusion Hepatitis C virus infection increases the risk of liver cirrhosis and liver cancer.Interferon combined with ribavirin therapy could effectively control the virus and improve outcomes.We can reduce the incidence of relapse by chosing the treatment of pegylated interferon instead of interferon and by completing the full treatment.

Effect of Hepatitis G Virus Infection on Chronic Hepatitis C

[The Coinfection of Hepatitis C Virus with Hepatitis G Virus and Its Reaction to Interferon Treatment].

A Clinical Epidemiological Study on HGV Infection with α-inter-feron Therapy

Hepatitis G Virus Infection in Chinese Patients with Chronic Hepatitis B, C or Non-a-e: Clinical and Molecular Aspects

Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections

The Incidence of Transfusion-Associated Hepatitis G Virus Infection and Its Relation to Liver Disease.

Prospective Evaluation of Infection with Hepatitis G Virus in Relation to Hepatocellular Carcinoma in Shanghai, China.

A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

Gb Virus C Infection in Patients with Hiv/Hepatitis C Virus Coinfection: Improvement of the Liver Function in Chronic Hepatitis C

Influence of HGV super-infected with HIV or HCV on the virus replication

Impact of Virus Genotype on Interferon Treatment of Patients with Chronic Hepatitis C: a Multicenter Controlled Study.

Gb Virus C (Gbv-C) Infection in Hepatitis C Virus (Hcv)/hiv-Coinfected Patients Receiving Hcv Treatment: Importance of the Gbv-C Genotype

Effect of Hepatitis C Virus (hcv) Genotype on Hcv and Hiv-1 Disease

Study of hepatitis G virus supper-infection in hepatitis B and C

Effect of Hepatitis C Virus Infection on the Outcomes of in Vitro Fertilization.

A five-year follow-up of one hundred and thirty-six patients of hepatitis C

The Effect of Cryoglobulinemia on the Antiviral Therapy in Patients with Chronic Hepatitis C

Study on clinical features of hepatitis G virus infection and HGV invasion to peripheral blood mononuclear cells

Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection

High Frequency of Hepatitis B Core and Surface Antibodies in Hepatitis C Virus-Infected Patients on the Screening Examination

Effects of Antiviral Agents and HBV Genotypes on Intrahepatic Covalently Closed Circular DNA in HBeAg-positive Chronic Hepatitis B Patients